Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

Market Cap	11.34B
Revenue (ttm)	6.52B
Net Income (ttm)	622.42M
Shares Out	2.52B
EPS (ttm)	0.25
PE Ratio	23.51
Forward PE	n/a
Dividend	0.20 (4.36%)
Ex-Dividend Date	May 31, 2024

Volume	17,964,801
Average Volume	26,845,534
Open	4.510
Previous Close	4.500
Day's Range	4.480 - 4.530
52-Week Range	3.910 - 5.540
Beta	0.34
RSI	53.07
Earnings Date	Aug 22, 2025

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In additio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 8,411
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600572

Financial Performance

In 2024, SHA:600572's revenue was 6.52 billion, a decrease of -3.23% compared to the previous year's 6.73 billion. Earnings were 622.42 million, an increase of 5.21%.